Need Help?

scRNA-seq from lung cancer organoids and immune cells

15 scRNA-seq samples were multiplexed, and 5' 10X Chromium scRNA-seq was performed. This dataset provides the FASTQ files for the multiplexed data, as well as the BAM files for the demultiplexed samples.

Request Access

HaikaLab data access policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom HaikaLab Immuno-Oncology research group grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: HaikaLab Immuno-Oncology research group and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. HaikaLab Immuno-Oncology research group: Biomedicum 1, Haartmaninkatu 8, 00290 Helsinki, Finland 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify HaikaLab Immuno-Oncology research group within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify HaikaLab Immuno-Oncology research group prior to any significant changes to the protocol for the Project. 14. The User Institution will notify HaikaLab Immuno-Oncology research group as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. HaikaLab Immuno-Oncology research group may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than HaikaLab Immuno-Oncology research group. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000593 RNASeq

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF50000196044 fastq.gz 464.5 MB
EGAF50000196045 fastq.gz 96.7 MB
EGAF50000196046 fastq.gz 88.9 MB
EGAF50000196047 fastq.gz 237.8 MB
EGAF50000196048 fastq.gz 106.4 MB
EGAF50000196049 fastq.gz 97.8 MB
EGAF50000196050 fastq.gz 460.2 MB
EGAF50000196051 fastq.gz 266.6 MB
EGAF50000196052 fastq.gz 93.7 MB
EGAF50000196053 fastq.gz 85.4 MB
EGAF50000196054 fastq.gz 229.0 MB
EGAF50000196055 fastq.gz 518.0 MB
EGAF50000196056 fastq.gz 96.9 MB
EGAF50000196057 fastq.gz 443.6 MB
EGAF50000196058 fastq.gz 88.8 MB
EGAF50000196059 fastq.gz 239.5 MB
EGAF50000196060 fastq.gz 421.7 MB
EGAF50000196061 fastq.gz 461.0 MB
EGAF50000196062 fastq.gz 1.2 GB
EGAF50000196063 fastq.gz 421.7 MB
EGAF50000196064 fastq.gz 463.1 MB
EGAF50000196065 fastq.gz 1.3 GB
EGAF50000196066 fastq.gz 3.0 GB
EGAF50000196067 fastq.gz 419.8 MB
EGAF50000196068 fastq.gz 3.0 GB
EGAF50000196069 fastq.gz 456.1 MB
EGAF50000196070 fastq.gz 1.2 GB
EGAF50000196071 fastq.gz 419.4 MB
EGAF50000196072 fastq.gz 458.5 MB
EGAF50000196073 fastq.gz 1.2 GB
EGAF50000196074 fastq.gz 2.9 GB
EGAF50000196075 fastq.gz 106.0 MB
EGAF50000196076 fastq.gz 105.8 MB
EGAF50000196077 fastq.gz 3.0 GB
EGAF50000196078 fastq.gz 235.2 MB
EGAF50000196079 fastq.gz 117.1 MB
EGAF50000196080 fastq.gz 470.3 MB
EGAF50000196081 fastq.gz 117.9 MB
EGAF50000196082 fastq.gz 263.5 MB
EGAF50000196083 fastq.gz 102.9 MB
EGAF50000196084 fastq.gz 101.9 MB
EGAF50000196085 fastq.gz 226.4 MB
EGAF50000196086 fastq.gz 453.0 MB
EGAF50000196087 fastq.gz 106.6 MB
EGAF50000196088 fastq.gz 106.1 MB
EGAF50000196089 fastq.gz 529.2 MB
EGAF50000196090 fastq.gz 236.8 MB
EGAF50000196091 fastq.gz 432.8 MB
EGAF50000196092 fastq.gz 390.0 MB
EGAF50000196093 fastq.gz 474.3 MB
EGAF50000196094 fastq.gz 1.1 GB
EGAF50000196095 fastq.gz 439.3 MB
EGAF50000196096 fastq.gz 392.4 MB
EGAF50000196097 fastq.gz 1.2 GB
EGAF50000196098 fastq.gz 2.8 GB
EGAF50000196099 fastq.gz 429.6 MB
EGAF50000196100 fastq.gz 384.7 MB
EGAF50000196101 fastq.gz 2.8 GB
EGAF50000196102 fastq.gz 1.1 GB
EGAF50000196103 fastq.gz 432.5 MB
EGAF50000196104 fastq.gz 388.1 MB
EGAF50000196105 fastq.gz 2.7 GB
EGAF50000196106 fastq.gz 1.1 GB
EGAF50000196107 fastq.gz 97.9 MB
EGAF50000196108 fastq.gz 88.7 MB
EGAF50000196109 fastq.gz 248.2 MB
EGAF50000196110 fastq.gz 474.8 MB
EGAF50000196111 fastq.gz 108.4 MB
EGAF50000196112 fastq.gz 97.4 MB
EGAF50000196113 fastq.gz 278.0 MB
EGAF50000196114 fastq.gz 2.7 GB
EGAF50000196115 fastq.gz 95.0 MB
EGAF50000196116 fastq.gz 85.2 MB
EGAF50000196117 fastq.gz 239.3 MB
EGAF50000196118 fastq.gz 534.2 MB
EGAF50000196119 fastq.gz 98.3 MB
EGAF50000196120 fastq.gz 88.5 MB
EGAF50000196121 fastq.gz 457.9 MB
EGAF50000196122 fastq.gz 249.8 MB
EGAF50000196123 fastq.gz 479.2 MB
EGAF50000196124 fastq.gz 467.5 MB
EGAF50000196125 fastq.gz 443.0 MB
EGAF50000196126 fastq.gz 1.3 GB
EGAF50000196127 fastq.gz 446.1 MB
EGAF50000196128 fastq.gz 472.3 MB
EGAF50000196129 fastq.gz 1.3 GB
EGAF50000196130 fastq.gz 3.1 GB
EGAF50000196131 fastq.gz 3.2 GB
EGAF50000196132 fastq.gz 441.4 MB
EGAF50000196133 fastq.gz 464.8 MB
EGAF50000196134 fastq.gz 1.3 GB
EGAF50000196135 fastq.gz 3.1 GB
EGAF50000196136 fastq.gz 442.4 MB
EGAF50000196137 fastq.gz 467.9 MB
EGAF50000196138 fastq.gz 1.3 GB
EGAF50000196139 fastq.gz 103.8 MB
EGAF50000196140 fastq.gz 108.1 MB
EGAF50000196141 fastq.gz 3.1 GB
EGAF50000196142 fastq.gz 256.7 MB
EGAF50000196143 fastq.gz 114.9 MB
EGAF50000196144 fastq.gz 485.3 MB
EGAF50000196145 fastq.gz 121.5 MB
EGAF50000196146 fastq.gz 288.7 MB
EGAF50000196147 fastq.gz 100.5 MB
EGAF50000196148 fastq.gz 103.3 MB
EGAF50000196149 fastq.gz 549.0 MB
EGAF50000196150 fastq.gz 246.7 MB
EGAF50000196151 fastq.gz 104.3 MB
EGAF50000196152 fastq.gz 108.3 MB
EGAF50000196153 fastq.gz 258.4 MB
EGAF50000196154 fastq.gz 466.4 MB
EGAF50000196155 fastq.gz 490.0 MB
EGAF50000196156 fastq.gz 300.0 MB
EGAF50000196157 fastq.gz 346.8 MB
EGAF50000196158 fastq.gz 884.3 MB
EGAF50000196159 fastq.gz 350.2 MB
EGAF50000196160 fastq.gz 302.9 MB
EGAF50000196161 fastq.gz 900.1 MB
EGAF50000196162 fastq.gz 2.1 GB
EGAF50000196163 fastq.gz 344.5 MB
EGAF50000196164 fastq.gz 2.2 GB
EGAF50000196165 fastq.gz 296.7 MB
EGAF50000196166 fastq.gz 877.6 MB
EGAF50000196167 fastq.gz 346.4 MB
EGAF50000196168 fastq.gz 299.0 MB
EGAF50000196169 fastq.gz 884.6 MB
EGAF50000196170 fastq.gz 2.1 GB
EGAF50000196171 fastq.gz 2.1 GB
EGAF50000196172 bam 2.3 GB
EGAF50000196173 bam 2.0 GB
EGAF50000196174 bam 2.3 GB
EGAF50000196175 bam 2.4 GB
EGAF50000196176 bam 1.7 GB
EGAF50000196177 bam 1.3 GB
EGAF50000196178 bam 2.3 GB
EGAF50000196179 bam 2.7 GB
EGAF50000196180 bam 6.4 GB
EGAF50000196181 bam 3.8 GB
EGAF50000196182 bam 1.4 GB
EGAF50000196183 bam 6.0 GB
EGAF50000196184 bam 4.3 GB
EGAF50000196185 bam 906.4 MB
EGAF50000196186 bam 4.3 GB
143 Files (134.4 GB)